Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DANIELL, EMILY

NPI: 1134657505 · EAST PROVIDENCE, RI 02914 · Acute Care Nurse Practitioner · NPI assigned 05/31/2017

$314K
Total Medicaid Paid
4,352
Total Claims
3,269
Beneficiaries
7
Codes Billed
2019-11
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 150 $4K
2020 555 $30K
2021 799 $47K
2022 440 $22K
2023 1,425 $160K
2024 983 $51K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,843 1,375 $112K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 883 636 $60K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 332 274 $53K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 627 435 $50K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 521 441 $22K
90792 Psychiatric diagnostic evaluation with medical services 114 82 $16K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 32 26 $2K